| Automated cassette-based production of high specific activity [203/212Pb] peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer M Li, X Zhang, TP Quinn, D Lee, D Liu, F Kunkel, BE Zimmerman, ... Applied Radiation and Isotopes 127, 52-60, 2017 | 46 | 2017 |
| Real nerve agent study assessing pyridyl reactivity: Selective fluorogenic and colorimetric detection of Soman and simulant Y Kim, YJ Jang, D Lee, BS Kim, DG Churchill Sensors and Actuators B: Chemical 238, 145-149, 2017 | 42 | 2017 |
| 203/212Pb theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer M Li, EA Sagastume, D Lee, D McAlister, AJ DeGraffenreid, KR Olewine, ... Current medicinal chemistry 27 (41), 7003-7031, 2020 | 30 | 2020 |
| Enhancing the efficacy of melanocortin 1 receptor-targeted radiotherapy by pharmacologically upregulating the receptor in metastatic melanoma M Li, D Liu, D Lee, S Kapoor, KN Gibson-Corley, TP Quinn, ... Molecular pharmaceutics 16 (9), 3904-3915, 2019 | 27 | 2019 |
| Modeling cell and tumor-metastasis dosimetry with the particle and heavy ion transport code system (PHITS) software for targeted alpha-particle radionuclide therapy D Lee, M Li, B Bednarz, MK Schultz Radiation research 190 (3), 236-247, 2018 | 27 | 2018 |
| Targeted alpha-particle radiotherapy and immune checkpoint inhibitors induces cooperative inhibition on tumor growth of malignant melanoma M Li, D Liu, D Lee, Y Cheng, NJ Baumhover, BM Marks, EA Sagastume, ... Cancers 13 (15), 3676, 2021 | 24 | 2021 |
| Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based Theranostics M Li, NJ Baumhover, D Liu, BS Cagle, F Boschetti, G Paulin, D Lee, Z Dai, ... Pharmaceutics 15 (2), 414, 2023 | 14 | 2023 |
| Compositions and methods of treating melanoma MK Schultz, FL Johnson, S Kapoor, D Lee, M Li, M Martin US Patent 11,179,484, 2021 | 5 | 2021 |
| Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors D Lee, M Li, D Liu, NJ Baumhover, EA Sagastume, BM Marks, P Rastogi, ... European journal of nuclear medicine and molecular imaging 51 (4), 1147-1162, 2024 | 3 | 2024 |
| Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy M Li, C Robles-Planells, D Liu, SA Graves, G Vasquez-Martinez, ... European journal of nuclear medicine and molecular imaging 51 (5), 1395-1408, 2024 | 2 | 2024 |
| Preclinical evaluation of 203/212Pb-based theranostics-dosimetry and renal toxicity. M Li, E Sagastume, D Zepeda-Orozco, H Wen, S Graves, D Lee, D Liu, ... Journal of Nuclear Medicine 61 (supplement 1), 289-289, 2020 | 2 | 2020 |
| MAPK-pathway inhibition driven changes in cellular thiol-redox state mediate drug resistance in metastatic melanoma S Kapoor, M Li, D Lee, E Sagastume, F Johnson, M Schultz Pigment Cell & Melanoma Research 33 (1), 191-191, 2020 | 2 | 2020 |
| Preclinical evaluation of 212Pb-based alpha-particle therapy for neuroendocrine tumors: Dosimetry and potential toxicities D Lee, S Graves, D Liu, H Wen, D Zepeda-Orozco, M Madsen, S Walsh, ... Journal of Nuclear Medicine 60 (supplement 1), 663-663, 2019 | 2 | 2019 |
| Simulation and Analysis of Human Phantoms Exposed to Heavy Charged Particle Irradiations Using the Particle and Heavy Ion Transport System (PHITS) D Lee Texas A & M University, 2012 | 2 | 2012 |
| Compositions and methods of treating melanoma MK Schultz, FL Johnson, S Kapoor, D Lee, M Li, M Martin US Patent 11,576,987, 2023 | 1 | 2023 |
| Enhancing efficacy of PRRT for neuroendocrine tumors by combining with everolimus and histone deacetylase inhibitors D Lee, M Li, D Liu, S Kapoor, J Prindle, A Smith, M Schultz PANCREAS 48 (3), 444-444, 2019 | 1 | 2019 |
| Preclinical evaluation of CXCR4 as novel radio-theranostic target for high grade neuroendocrine and neuroblastoma tumors D Liu, M Li, A Bellizzi, Y Menda, D Lee, K Nourmahnad, S Ghobrial, ... Journal of Nuclear Medicine 59 (supplement 1), 1313-1313, 2018 | 1 | 2018 |
| On the Use of 203Pb Imaging to Inform 212Pb Dosimetry for 203/212Pb Image-Guided Alpha-Particle Therapy for Cancer S Graves, M Li, D Lee, MK Schultz Beyond Becquerel and Biology to Precision Radiomolecular Oncology …, 2024 | | 2024 |
| [212Pb] PSC-PEG2-TOC Therapy for NET Leads to Complete Responses in Mice Bearing SSTR2 Positive Tumors-Comparison to [177Lu] DOTATATE in a Preclinical Model MK Schultz, D Liu, M Li, BS Cagle, Z Dai, D Lee, K Orcutt, E Sagastume, ... Endocrine Abstracts 89, 2023 | | 2023 |
| Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac] Ac-DOTATATE in preclinical model L Dijie, M Li, Z Dai, B Cagle, D Lee, M Schultz Nuclear medicine and biology 126 (Suppl.), 2023 | | 2023 |
